skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Differences in the relative myocardial/organ ratios of iodine-123-BMIPP and the dimethyl-substituted iodine 123-DMIPP fatty acid analogue in humans

Journal Article · · Journal of Nuclear Medicine
OSTI ID:563346
; ;  [1]
  1. Free Univ. Hospital, Amsterdam (Netherlands); and others

Radioiodinated fatty acid analogues, modified by methyl-substitution are used for SPECT imaging of the heart. The effect of mono- and dimethyl-substitution on biodistribution was investigated in humans to evaluate their relative merits for SPECT image quality. Planar total body scans were performed in fasting patients with coronary artery disease, but without heart failure, one hour after administration of 111 MBq 15-(p-[I-123]-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP, n=7) or III MBq 15-(p-[I-123]-iodophenyl)-3,3-dimethylpentaderanoic acid (DMIPP, n=4). Because these branched fatty acids are used for cardiac imaging, we focussed on heart/organ ratios, by comparing small roi-counts in heart, liver, lung, muscle (thigh) and bladder. Statistical analysis: t-test for unpaired data. Both tracers showed good visualization of the heart. While DMIPP showed a relatively high liver uptake, increased background, ie lung, activity was found for BMIPP. In contrast to DMIPP, BMIPP also showed elevated activity in the bladder.

OSTI ID:
563346
Report Number(s):
CONF-970602-; ISSN 0161-5505; TRN: 97:004028-0018
Journal Information:
Journal of Nuclear Medicine, Vol. 38, Issue Suppl.5; Conference: 44. annual meeting of the Society of Nuclear Medicine, San Antonio, TX (United States), 2-5 Jun 1997; Other Information: PBD: May 1997
Country of Publication:
United States
Language:
English